Simona Ronchetti
Overview
Explore the profile of Simona Ronchetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alhosseini M, Maddalon A, Cari L, Ronchetti S, Migliorati G, Corsini E, et al.
Arch Toxicol
. 2025 Mar;
PMID: 40025135
While being banned in the European Union, the herbicide atrazine (ATR) is still one of the most used herbicides in the world. ATR is classified as an endocrine disruptor, but...
2.
Adorisio S, Fierabracci A, Cham B, Hoang V, Thuy Linh N, Nhung L, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770403
The expression of oncogene zinc-finger protein 217 (ZNF217) has been reported to play a central role in cancer development, resistance, and recurrence. Therefore, targeting ZNF217 has been proposed as a...
3.
Buoso E, Masi M, Limosani R, Fagiani F, Oliviero C, Colombo G, et al.
J Crohns Colitis
. 2024 Dec;
19(1.
PMID: 39693354
Background And Aims: Given the role of Receptor for Activated C Kinase 1 (RACK1) in both immune cell activation and in the maintenance of the intestinal epithelial barrier integrity, we...
4.
Gentili M, Sabbatini S, Nunzi E, Lusenti E, Cari L, Mencacci A, et al.
Biomolecules
. 2024 Oct;
14(10).
PMID: 39456254
Inflammatory bowel diseases (IBD) have a complex, poorly understood pathogenesis and lack long-lasting effective treatments. Recent research suggests that intestinal fungal dysbiosis may play a role in IBD development. This...
5.
Leoncini G, Ronchetti S, Villanacci V
Dig Liver Dis
. 2024 May;
56(8):1420.
PMID: 38806327
No abstract available.
6.
Leoncini G, Cari L, Ronchetti S, Donato F, Caruso L, Calafa C, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38339134
A structural weakness of the mucus barrier (MB) is thought to be a cause of ulcerative colitis (UC). This study aims to investigate the mucin (MUC) composition of MB in...
7.
Paglialunga M, Flamini S, Contini R, Febo M, Ricci E, Ronchetti S, et al.
Cells
. 2023 Sep;
12(18).
PMID: 37759516
Glucocorticoids (GCs) are commonly used to treat autoimmune and inflammatory diseases, but their clinical effects and long-term use can lead to serious side effects. New drugs that can replace GCs...
8.
Alhosseini M, Palazzo M, Cari L, Ronchetti S, Migliorati G, Nocentini G
Int J Mol Sci
. 2023 Mar;
24(5).
PMID: 36901957
B-acute lymphoblastic leukemia (B-ALL) is one of the most common pediatric cancers, wherein regulatory T cells (Treg) and exhausted CD8 T cells may be important in its development and maintenance....
9.
Cari L, Rosati L, Leoncini G, Lusenti E, Gentili M, Nocentini G, et al.
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36768553
Ulcerative colitis (UC) and Crohn's Disease (CD) are chronic relapsing inflammatory diseases that are caused by genetic, environmental, and immune factors. Treatment strategies are currently based on symptomatic control by...
10.
Leoncini G, Gentili M, Lusenti E, Caruso L, Calafa C, Migliorati G, et al.
Pharmacol Res
. 2022 Jul;
182:106353.
PMID: 35835370
Glucocorticoid-induced leucin zipper (GILZ) mediates the effects of glucocorticoids in immune cells, but little is known about its role in both the gastro-intestinal (GI) mucosa and inflammatory bowel diseases (IBD)...